Sara Elford worked in the capital markets industry for more than twenty years, beginning in investment banking in New York in 1994. She transitioned to equity research in Canada in 1996 as generalist analyst following primarily small and mid capitalization growth companies until 2015. Since then, Sara has served on seven boards for companies listed on either the TSX-V, TSX and/or Nasdaq. She currently serves on the boards of BioSyent Inc., BQE Water Inc. and Xebec Adsorption Inc. She also previously served on the boards of Carmanah Technologies Corp., Hydrogenics Corp., Pure Technologies Ltd., and TSO3 Inc., all of which were acquired. Sara earned her CFA Charterholder designation in 1997 and completed the academic requirements for the directors’ education program with the ICD in 2015. She is a graduate of Bishop’s University (Finance Major and Economics Minor).